Gewebenähe-Indikatorschwelle für die Herzablation
Anmelder: Biosense Webster (Israel) Ltd. 🇮🇱
Details
- Veröffentlichungs-Nr.
- EP4740883
- Anmeldetag
- 10. November 2025
- Veröffentlichung
- 13. Mai 2026
- Rechtsraum
- EP
- IPC
- A61B18/12(PAPPONE CARLO et al.)
Abstract
In one exemplary mode, an apparatus includes a catheter including an electrode to provide an intracardiac electrogram (IEGM) signal and a signal used to sense impedance, an ablation energy generator configured to conduct ablative energy to the electrode of the catheter based on user input, a controller configured to sample the IEGM signal from the electrode before and after a given ablation, and sense impedance between the electrode and tissue, and a processor configured to compare the sensed impedance with a TPI threshold to determine a contact status of the electrode with respect to the tissue, render to a display an indication of the determined contact status, compute a change in the IEGM signal due to the given ablation, and adjust the TPI threshold for subsequent ablations based on the computed change in the IEGM signal due to the given ablation of the tissue with the electrode.
Anmelder
- Firma
- Biosense Webster (Israel) Ltd.
- Land
- 🇮🇱 Israel
Israelische Gesellschaft eines Medizintechnikunternehmens, die Kathetersysteme und Geräte für die kardiologische Diagnostik und Behandlung von Herzrhythmusstörungen entwickelt.
1.804 Patente in unserer Datenbank